683P Impact of renin-angiotensin system inhibitors (RASi) on outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI)

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Renin Angiotensin System ◽

Angiotensin System ◽

Renin Angiotensin

Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma

International Urology and Nephrology ◽

10.1007/s11255-021-03042-y ◽

2021 ◽

Author(s):

Yuki Nemoto ◽

Hiroki Ishihara ◽

Kazutaka Nakamura ◽

Hidekazu Tachibana ◽

Hironori Fukuda ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Elderly Patients ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Efficacy And Safety

Nephrectomy after complete response to immune checkpoint inhibitors for metastatic Renal Cell Carcinoma (mRCC): A new surgical challenge?

European Urology Open Science ◽

10.1016/s2666-1683(20)33432-7 ◽

2020 ◽

Vol 19 ◽

pp. e1264

Author(s):

G. Pignot ◽

A. Thiery-Vuillemin ◽

J. Walz ◽

H. Lang ◽

P. Werle ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Complete Response

THE ROLE OF IMMUNE CHECKPOINT INHIBITORS ( ICI) IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA ( MRCC) IN OLDER ADULTS IN AN ASIAN POPULATION

Journal of Geriatric Oncology ◽

10.1016/s1879-4068(19)31195-6 ◽

2019 ◽

Vol 10 (6) ◽

pp. S47

Author(s):

R. Kanesvaran ◽

J. Chan ◽

H.S. Tan ◽

J. Hong ◽

T. Rajasekaran ◽

...

Keyword(s):

Older Adults ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Asian Population

Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge?

European Urology ◽

10.1016/j.eururo.2019.12.018 ◽

2020 ◽

Vol 77 (6) ◽

pp. 761-763 ◽

Cited By ~ 8

Author(s):

Geraldine Pignot ◽

Antoine Thiery-Vuillemin ◽

Jochen Walz ◽

Hervé Lang ◽

Pierre Bigot ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Complete Response

Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: Report of three cases

International Journal of Urology ◽

10.1111/j.1442-2042.2008.02102.x ◽

2008 ◽

Vol 15 (9) ◽

pp. 848-850 ◽

Cited By ~ 7

Author(s):

Manabu Tatokoro ◽

Yasuhisa Fujii ◽

Satoru Kawakami ◽

Naotaka Fukui ◽

Yoshinobu Komai ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Combination Treatment ◽

Renal Cell ◽

Renin Angiotensin System ◽

Cyclooxygenase 2 ◽

Angiotensin System ◽

Renin Angiotensin

Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) analysis

Journal of Geriatric Oncology ◽

10.1016/j.jgo.2021.02.022 ◽

2021 ◽

Author(s):

Daniel V. Araujo ◽

J. Connor Wells ◽

Aaron R. Hansen ◽

Nazli Dizman ◽

Sumanta K. Pal ◽

...

Keyword(s):

Older Adults ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors

Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic review

Expert Review of Molecular Diagnostics ◽

10.1080/14737159.2019.1680286 ◽

2019 ◽

Vol 20 (2) ◽

pp. 169-185 ◽

Cited By ~ 5

Author(s):

Sara Elena Rebuzzi ◽

Fabiana Perrone ◽

Melissa Bersanelli ◽

Giacomo Bregni ◽

Michele Milella ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Molecular Biomarkers

Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.10.019 ◽

2020 ◽

Author(s):

Jad Chahoud ◽

Pavlos Msaouel ◽

Jeremy A. Ross ◽

Barrett Z. McCormick ◽

Tharakeswara K. Bathala ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors

Immune‐related adverse events as clinical biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors

The Oncologist ◽

10.1002/onco.13868 ◽

2021 ◽

Author(s):

Dylan J. Martini ◽

Subir Goyal ◽

Yuan Liu ◽

Sean T. Evans ◽

T. Anders Olsen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Adverse Events ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors ◽

Clinical Biomarkers

Editorial Comment to A case of sarcoidosis‐like reaction associated with immune checkpoint inhibitors in metastatic renal cell carcinoma

IJU Case Reports ◽

10.1002/iju5.12393 ◽

2021 ◽

Author(s):

Toshiki Kijima

Keyword(s):

Renal Cell Carcinoma ◽

Editorial Comment ◽

Cell Carcinoma ◽

Immune Checkpoint ◽

Renal Cell ◽

Checkpoint Inhibitors